Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
October 21, 2014, 12:48:02 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 642843
  • Total Topics: 48904
  • Online Today: 213
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Honouring a POZ hero from South Africa  (Read 1832 times)

0 Members and 1 Guest are viewing this topic.

Offline LizinSA

  • member
  • Posts: 1
Honouring a POZ hero from South Africa
« on: October 10, 2012, 09:34:01 AM »
I have just despatched a book into cyberspace, courtesy of amazon.com, and itís a wonderful feeling.  Khabzela. I actually wrote it seven years ago, soon after returning to South Africa after several years in London, working on a national newspaper.  I had watched with some frustration the way South Africa was portrayed:  Aids was now the prism through which it was viewed. The government had just won the case against the pharmaceutical companies, forcing them to allow generic anti-retroviral  drugs and thus make it affordable to treat the hundreds of thousands of South Africans infected with the HI virus.  Now the blame shifted  to the president, Aids dissident, Thabo Mbeki.   Perceptions of South Africa were reduced to villain vs victim: uncaring, remote Big Man president  as the only obstacle to life-saving medication for his hapless, helpless people.
 When I got back to South Africa in 2003,  I found of course, that it was a noisy, fractious democracy but  the silence on the subject of HIV/Aids was deafening.  This couldnít surely be pinned on one man.
Then Khabzela, the hottest DJ on the hottest youth radio station in South Africa, Yfm, came out on air with his positive HIV diagnosis.   I interviewed him for POZ but he was already suffering from dementia and he died a few months later, having refused to take ARV medication. Mbekiís confusing messages about the cause of Aids might have contributed to this refusal but certainly didnít explain it.  For the next year, I explored his life in an attempt to understand why.  I interviewed his family, his childhood friends, his girlfriends, his colleagues at Yfm and in the taxi industry, his sangoma and the dodgy white miracle peddlers he turned to in his increasing desperation. Finally, I sat down with the piles of transcripts of numerous interviews. How to write it? Khabzela and I were both South Africans but apartheidís rigid racial divide meant we could have grown up in  two different countries.  I now had control of how to frame his story. How not to emulate the same pigeon-holing I had been so critical of in London?  Unless I went about this with maximum self-awareness, I too was going to shape the story to fit my own preconceptions. And no matter how empathetic I was, I could not claim to be familiar with the intimate agonies and yearnings of a black man who had grown up under apartheid.
I decided I could not use the traditional biographical tool of omniscient narrator. I made myself a  peripheral character in the book, trying to  be upfront about where I was coming from. For the rest, I used as far as possible verbatim quotes from my interviewees so that they got to tell their stories in their own words. I was simply the conduit,  channelling it all together into a coherent narrative. I remember falling into quite an intense depression in the months I was writing Khabzela. Analysing it afterwards,  it was clear why.  The interviews had been done while Khabzela was dying and shortly after his death.  Virtually everyone I spoke to was still in the throes of shock and grief Ė and fear. If it happened to Khabzela, it could happen to them too. These were the voices that were swilling around in my head in those long, lonely months of writing.
Khabzela died in 2004. This book was first published  the following year,  in  2005.
It became a best-seller in South Africaís undemanding terms: selling nearly 5,000 copies.  The author gets 10% of the proceeds, going up to 12% for the second print run.  In the seven years since its publication, I have made enough to pay the bills for almost  two  full months.
But, as with the research and writing of  the book, it has taken me to interesting places.  Zackie Achmat, South Africaís leading HIV-positive hero, got me to address activists at the then ground-breaking Treatment Action Campaign. And later to sit on a panel at an Aids conference he chaired, consisting of celebritiesí experience of Aids.    In the cavernous waiting room of the  HIV/Aids unit at a major state hospital,  I stood on a plastic chair and, aided by a translator,  related Khabzela as cautionary tale to the captive patients: this is what will happen to you if you donít take your medication.
I was whisked off to a castle on a lake in Salzburg to pontificate on biography-as-mirror-of-society in the illustrious society of Claire Tomalin and Vikram Seth.
And now Khabzela is taking me on yet another journey.
Publishing has been revolutionized since I first handed over my manuscript in 2005.  Then the author was reduced to bystander as the publisher, with exclusive licence over oneís work, took  control of print runs, distribution, pricing and marketing.   I have a different publisher now but I think that, generally, the relationship between publisher and author has shifted with the coming of the digital age to become more of a partnership. 
My latest royalty statement showed ever dwindling sales. I knew Khabzela was being prescribed at US universities but to get the physical copy there is expensive.
Digital publishing transforms all that.  It also offers the prospect of once again having control of the manuscript I had sweated and wept over.  I dug out the contract I had signed in 2005 which confirmed I had not ceded rights to the electronic version of Khabzela and began re-editing and updating the original manuscript.  Much has changed in South Africa since then: only a few years ago, hundreds of thousands of people were dying of Aids with no hope of affordable treatment.  Now South Africa is the poster boy of the international Aids community, with the biggest HIV/Aids programme in the world, largely funded by the government.

Amazon is remarkably user-friendly. I downloaded their idiotís guide to converting a Word document to an e-book. My friend, Dirk Hartford, the founding CEO of Yfm and the man who spotted and cultivated Khabzela,  sent me some of his old pictures of him and I chose a particularly evocative one, cropped it on my Mac and Masha turned it into a digital cover. Loading the book into the Kindle shop is fairly simple: you are given a few choices. On pricing, for example. If you opt to price it at anything over $9.99, you can only opt for a 35-65% royalty split with Amazon. They get the 65%.  Price it under 9.99 and you get 70%, although 30% then gets lopped off in tax for sales in the US. I chose an arbitrary middle ground: $5.99 but when it popped up for sale for the first time on the amazon.com website this morning, it was priced at $7.99. Who knows if it will find any takers at all? But, itís a good feeling, being in control. And launching Khabzela off on another life, out there in the ether.


Offline magnoman

  • Member
  • Posts: 26
Re: Honouring a POZ hero from South Africa
« Reply #1 on: December 01, 2012, 04:43:28 PM »
Just picked up a copy Liz.

Hope it sells well for you.  Sounds like quite a story.

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.